LIPAC ONCOLOGY Trademark

Trademark Overview


On Tuesday, September 19, 2017, a trademark application was filed for LIPAC ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the LIPAC ONCOLOGY trademark a serial number of 87614578. The federal status of this trademark filing is REGISTERED as of Tuesday, June 26, 2018. This trademark is owned by Lipac Oncology LLC. The LIPAC ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
lipac oncology

General Information


Serial Number87614578
Word MarkLIPAC ONCOLOGY
Filing DateTuesday, September 19, 2017
Status700 - REGISTERED
Status DateTuesday, June 26, 2018
Registration Number5501156
Registration DateTuesday, June 26, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements


Description of MarkThe mark consists of Geometric figure comprised of circles and ovals clustered to create a partial circle swirl design with the words "LIPAC ONCOLOGY" directly to the right of the design.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"ONCOLOGY"
Goods and ServicesPharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 25, 2017
Primary Code042
First Use Anywhere DateTuesday, November 1, 2016
First Use In Commerce DateTuesday, November 1, 2016

Trademark Owner History


Party NameLIPAC ONCOLOGY, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameLipac Oncology LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Party NameLipac Oncology LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPomona, CA 91768

Party NameLipac Oncology LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPomona, CA 91768

Trademark Events


Event DateEvent Description
Friday, December 22, 2017ASSIGNED TO EXAMINER
Wednesday, January 3, 2018PRIORITY ACTION WRITTEN
Friday, September 22, 2017NEW APPLICATION ENTERED
Monday, September 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 3, 2018PRIORITY ACTION E-MAILED
Wednesday, January 3, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, February 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 8, 2018ASSIGNED TO LIE
Tuesday, March 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 26, 2018REGISTERED-PRINCIPAL REGISTER
Friday, June 7, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, June 26, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED